Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio - 6-MTH group results

Nov 11 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2025        Sep 30, 2024      Mar 31, 2026  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             18.79               19.76             42.10     
                 (-4.9 pct)          (+3.4 pct)        (-6.5 pct)   
  Operating       loss 2.34            417 mln          loss 4.00   
                                     (-70.4 pct)                    
  Recurring       loss 2.49            549 mln          loss 4.40   
                                     (-65.6 pct)                    
  Net             loss 6.91            513 mln          loss 9.00   
                                     (-52.7 pct)                    
  EPS          loss 57.40 yen         4.26 yen       loss 74.74 yen 
  Ann Div                             17.00 yen            NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                             17.00 yen            NIL      
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news